INTRODUCTION
============

Some dental patients have histories of adverse reactions to local anesthesia. Such adverse reactions are caused by intoxication (overdose), which results from intravascular injection or the rapid absorption of high doses of drugs, side effects associated with vasoconstrictors, the vasovagal reflex, anxiety, and a psychosomatic reaction \[[@R1]-[@R4]\]. In reality, true allergic reactions to local anesthetics are rare \[[@R5],[@R6]\]. It has been estimated that only about 1% of all reactions occurring during local anesthesia are allergic in origin \[[@R7]\]. Allergic reactions have been shown to be caused by co-incidental exposure to other antigens such as preservatives (e.g., methyl-p-hydroxybenzoate), antioxidants (e.g., bisulphate), antiseptics (e.g., chlorhexidine), and other antigens such as latex, as well as local anesthetic drugs \[[@R8]-[@R10]\]. Many patients with histories of adverse reactions to local anesthesia have the impression that they are allergic to local anesthetics. In our institute, we have performed allergy tests in patients with histories of adverse reactions to local anesthesia. The test is mainly for detecting immediate allergy (anaphylaxis), because it rapidly occurs and is the most severe of all allergic reactions, resulting in potentially fatal consequences.

The aim of the present study was to investigate the frequency of allergy to local anesthetics in dental patients with histories of adverse reactions to local anesthesia based on the results of allergy tests in our institute over a period of 5 years.

PATIENTS AND METHODS
====================

This study was approved by the Ethics Committee of Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences (No. 358). We investigated the past medical records of dental patients retrospectively. In the period from April 2004 to March 2009, twenty patients (3 males and 17 females) with histories of adverse reactions to local anesthesia were studied. The age was 45.2 ± 16.8 years old, ranging from 17 to 77. Ten patients had other allergens, including other drugs such as cephalosporium antibiotics, metals, alcohol, animals, house dust, pollen, and foods such as fish, eggs, milk, and soybean products. Four patients had a history of skin manifestations as the clinical symptoms of adverse reactions after the injection of local anesthetics, six had circulatory symptoms, three had respiratory symptoms, eight had central nervous symptoms, and three had other symptoms. According to the guidelines proposed by Barbaud, *et al.* \[[@R11]\], patients who have histories of erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, or leucocytoclastic vasculitis on histological examination caused by local anesthetics should be excluded from allergy tests. However, none of our patients showed such conditions.

We took precautions for emergency treatment, regularly monitoring the blood pressure, pulse, and electrocardiogram during the allergy test. Intracutaneous tests were performed in seventeen patients, challenge tests were conducted in thirteen, and both were carried out in ten patients. The commercial products of local anesthetics injected for intracutaneous tests were as follows: Xylocaine® Injection Polyamp 2% for eight patients, Xylocaine® Injection 2% for two patients, Scandonest® cartridge 3% for one patient, Xylocaine® Injection Polyamp 2% and Scandonest® cartridge 3% for three patients, and Xylocaine® Injection Polyamp 2% plus Xylocaine® Injection 2% for two patients. On the other hand, the commercial products of local anesthetics injected for challenge tests were as follows: Xylocaine® Cartridge for Dental Use in eight patients, Xylocaine® Injection Polyamp 2% in three patients, Scandonest® cartridge 3% in one patient, Xylocaine® Cartridge for Dental Use plus Xylocaine® Injection Polyamp 2% in one patient, and Xylocaine® Cartridge for Dental Use plus Xylocaine® Injection 2% in one patient.

Our methods for detecting immediate allergy to local anesthetics were as follows:

1). Intracutaneous Test:
------------------------

An intracutaneous test was performed using local anesthetics, including lidocaine hydrochloride (Xylocaine® Injection Polyamp 2%, AstraZeneca K.K. Osaka, Japan or Xylocaine® Injection 2%, AstraZeneca K.K. Osaka, Japan) and mepivacaine hydrochloride (Scandonest® cartridge 3%, Nippon Shika Yakuhin Co., Ltd., Yamaguchi, Japan). Some agents were diluted sequentially (1/100 or 1/10) with 0.9% saline, if needed. Local anesthetics were injected on the extensor surface of the arm in a small volume (0.02 ml) that produces a wheal of a few mm in diameter. As a negative control, saline was injected. Redness or swelling in the area around the injection site was measured every 5 minutes until 20 minutes, and the judgments were as follows: a positive response, redness of more than 20 mm; a false-positive response, redness of 10-19 mm; or a negative response, redness of less than 10 mm in diameter. When general symptoms, which were applicable to the criteria, occurred at the time of the test, we judged it to be a false-positive or positive response.

2). Challenge Test:
-------------------

Following the intracutaneous test, a challenge test was performed using the local anesthetics, including lidocaine hydrochloride (Xylocaine® Injection Polyamp 2%, AstraZeneca K.K. Osaka, Japan or Xylocaine® Injection 2%, AstraZeneca K.K. Osaka, Japan), lidocaine hydrochloride with 0.0125 mg adrenaline per 1ml of lidocaine (Xylocaine® Cartridge for Dental Use, Dentsply-Sankin, Tokyo, Japan), and mepivacaine hydrochloride (Scandonest® cartridge 3%, Nippon Shika Yakuhin Co., Ltd., Yamaguchi, Japan). One or two kinds of anesthetic were injected into the oral mucosa in a dose range from 0.1 to 1.0 ml incrementally, and local findings around the injection site, general symptoms, and vital signs were observed until 30 minutes. The criteria for general symptoms in the challenge test are shown in Table **[1](#T1){ref-type="table"}**.

Table **[2](#T2){ref-type="table"}** shows the anesthetics and adjuvants contained in commercial products used for the allergy tests.

RESULTS
=======

The results of intracutaneous tests showed a positive reaction to Scandonest® cartridge 3% in one patient, false-positive reactions to Xylocaine® Injection Polyamp 2% and Xylocaine® Injection 2% in one patient, and a false-positive reaction to Xylocaine® Injection 2% in one patient (Fig. **[1](#F1){ref-type="fig"}**). A challenge test for the patient who showed a positive reaction on the intracutaneous injection of Scandonest® was avoided. The results of the challenge test showed a false-positive reaction to Xylocaine® Cartridge in one patient (Fig. **[2](#F2){ref-type="fig"}**).

For the overall results of all tests, three patients showed a positive or false-positive reaction to local anesthetics. Detailed results for each case are as follows:

Case 1:
-------

This patient was a 54-year-old woman. She had been diagnosed with an allergy to Xylocaine® in another hospital through a previous allergy test, so an allergy test for another local anesthetic for dental treatment was needed. This resulted in a positive reaction to Scandonest® in the intracutaneous test, suspected to be a true allergy.

Case 2:
-------

This patient was a 57-year-old man. She had a history of losing consciousness when receiving local anesthesia for dental treatment. The patient showed false-positive reactions to Xylocaine® Injection Polyamp 2% and Xylocaine® Injection 2% in intracutaneous tests, and so underwent tooth extraction under general anesthesia a few days later. There was no problem on tooth extraction.

Case 3:
-------

This patient was a 68-year-old woman. She had a history of dyspnea when receiving local anesthesia for dental treatment. The patient showed a false-positive reaction to Xylocaine® Injection Polyamp 2% in the intracutaneous test and a false-positive reaction to Xylocaine® Cartridge for Dental Use in the challenge test, suspected to be immediate allergy (anaphylaxis). She underwent dental treatment using diphenhydramine hydrochloride as an alternative to local anesthetic a few days later (Venasmin® Injection 3%), which has been reported to be as effective as local anesthesia. There was no problem with the dental treatment.

DISCUSSION
==========

The intracutaneous test is a simple and easy method and has often been used as a means of identifying safe local anesthetics for patients with histories of adverse reactions \[[@R12]\]. However, it has been reported to be of no value in the diagnosis of reactions to local anesthetics \[[@R13]\] because it is unclear whether an adverse reaction is due to a local anesthetics or other factors \[[@R4]\]. The molecular weight of a local anesthetic is too low to elicit a positive reaction in a skin test even if the patient has an allergy to a local anesthetic \[[@R14]\]. On the other hand, provocative challenge has been thought to be the gold standard for the diagnosis of drug allergy \[[@R2]\]. Since there is no reliable in vitro test for allergy, the challenge test, which confirms the reproduction of symptoms by administering drugs, is thought to be the most reliable. However, because there is a possibility of causing an immediate allergy (anaphylaxis) at the time of the test, it is essential to obtain all relevant medical information from patients and perform the challenge test in an environment with an appropriate emergency system.

It is possible that every drug may cause an allergic reaction to some people, but it is difficult to predict this before administration. Local anesthetics are some of the rarest drug allergens. Our results suggest that the frequency of allergy to local anesthetics is low even if patients have histories of adverse reactions to local anesthesia. However, there are some patients with possible allergy to local anesthetics. In such cases, we have to prepare alternative agents. A candidate offering an alternative to local anesthetics is diphenhydramine hydrochloride, with an effect reportedly equal to 1% lidocaine and no crossreactivity to local anesthetics \[[@R15]\]. It was used in case 3 in our institute, resulting in no problem on tooth extraction. In other cases, some of these patients will have to receive general anesthesia for dental treatment without local anesthesia. We have to explain the alternatives to local anesthesia if a patient has a possible allergy to local anesthetics.

An allergy to local anesthetics is thought to be a type IV reaction at rates of between 80 and 90%. This means that the majority of allergic reactions occur as allergic contact dermatitis \[[@R16]\]. Because the frequency of adding local anesthetics to general commercial drugs is gradually increasing, resulting in an increase in the frequency of sensitization, rates of allergy to local anesthetics may increase in the future. Therefore, we will have more opportunities to investigate allergy to local anesthetics. Dentists, who often use local anesthetics, have to pay more attention to such allergy. Allergy tests of local anesthetics should be performed in patients in whom it is uncertain if they are allergic, and patients should undergo dental treatment only after it has been confirmed that a local anesthetic can be used safely.

![The rates of patients showing a positive, false-positive, or negative reaction to local anesthetics in intracutaneous tests.](TODENTJ-5-146_F1){#F1}

![The rates of patients showing a false-positive or negative reaction to local anesthetics in challenge tests. There were no patients with a positive reaction.](TODENTJ-5-146_F2){#F2}

###### 

Criteria for General Symptoms in the Challenge Test

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Diagnosed as a positive reaction when there are two or more predominant symptoms, and as a false-positive reaction when there is one predominant symptom or more than one of the other symptoms:
  \[Predominant symptoms\]
  Rash or erythema of the skin (strong color and area, wheal or urticaria)High level hypotension, nonpalpable pulseBronchospasm or respiratory distress due to upper respiratory tract edemaFacial edema
  \[Other symptoms\]
  Neurologic symptoms (consciousness disorder and others)Gastrointestinal symptoms
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

Anesthetics and Adjuvants Contained in the Commercial Products Used for Allergy Tests

  Trade Name                            Anesthetic (Per/ml)                 Adjuvant (Per/ml)            
  ------------------------------------- ----------------------------------- ------------------- -------- ---------------------------------
  Xylocaine® Injection Polyamp 2%       Lidocaine hydrochloride (20 mg)     (-)                 (-)      (-)
  Xylocaine® Injection 2%               Lidocaine hydrochloride (20 mg)     (-)                 (-)      1 mg
  Xylocaine® Cartridge for Dental Use   Lidocaine hydrochloride (20 mg)     0.0125 mg           0.6 mg   1 mg[\*](#T1FN1){ref-type="fn"}
  Scandonest® cartridge 3%              Mepivacaine hydrochloride (30 mg)   (-)                 (-)      (-)

Methylparaben has not used since 2007
